Ray, Joshua A <br/><br/>
Cost-utility analysis of cinacalcet in addition to standard of care in the UK.  [electronic resource] 

 -  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association  Nov 2007 
 - 3355-7; author reply 3357-8 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>0931-0509 
<br/><br/><label>Standard No.: </label>10.1093/ndt/gfm434  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cinacalcet<br/>Cost-Benefit Analysis<br/>Humans<br/>Hyperparathyroidism, Secondary--drug therapy<br/>Kidney Failure, Chronic--complications<br/>Naphthalenes--economics<br/>Parathyroid Hormone--blood<br/>United Kingdom